Animal models of lung cancer: Phenotypic comparison of different animal models of lung cancer and their application in the study of mechanisms

Abstract

Lung cancer has one of the highest rates of incidence and mortality worldwide, making research on its mechanisms and treatments crucial. Animal models are essential in lung cancer research as they accurately replicate the biological characteristics and treatment outcomes seen in human diseases. Currently, various lung cancer models have been established, including chemical induction models, orthotopic transplantation models, ectopic transplantation models, metastasis models, and gene editing mouse models. Additionally, lung cancer grafts can be categorized into two types: tissue-based and cell-based grafts. This paper summarizes the phenotypes, advantages, and disadvantages of various induction methods based on their modeling techniques. The goal is to enhance the simulation of clinical lung cancer characteristics and to establish a solid foundation for future clinical research.

Keywords

animal models of lung cancer / chemical induction methods / gene editing mouse models / lung cancer grafts / transplantation models

References

[1] Debnath CR, Shahjahan SM, Debnath MR, et al. Parotid gland metastasis - an unusual presentation of adenocarcinoma of lung. Mymensingh Med J. 2015; 24(1): 175-177.

[2] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3): 229-263.

[3] Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016; 48(3): 889-902.

[4] Nishida C, Yatera K. The impact of ambient environmental and occupational pollution on respiratory diseases. Int J Environ Res Public Health. 2022; 19(5): 2788.

[5] Salehiniya H, Bahadori M, Ghanizadeh G, Raei M. Epidemiological study of lung cancer in Iran: a systematic review. Iran J Public Health. 2022; 51(2): 306-317.

[6] Liu X, Wang J, Yang Z, et al. Upregulated DNMT3a coupling with inhibiting p62-dependent autophagy contributes to NNK tumorigenicity in human bronchial epithelial cells. Ecotoxicol Environ Saf. 2024; 286(Nov 1): 117157.

[7] Hartog M, Zhang QY, Ding X. Role of mouse cytochrome P450 enzymes of the Cyp2abfgs subfamilies in the induction of lung inflammation by cigarette smoke exposure. Toxicol Sci. 2019; 172(1): 123-131.

[8] Ali NA, Elsayed GH, Mohamed SH, et al. Chia seed (Salvia hispanica) attenuates chemically induced lung carcinomas in rats through suppression of proliferation and angiogenesis. Pharmaceuticals (Basel). 2024; 17(9): 1129.

[9] Chikara S, Mamidi S, Sreedasyam A, et al. Flaxseed consumption inhibits chemically induced lung tumorigenesis and modulates expression of phase II enzymes and inflammatory cytokines in a/J mice. Cancer Prev Res (Phila). 2018; 11(1): 27-37.

[10] Sonkar AB, Verma A, Yadav S, et al. Antiproliferative, apoptotic and anti-inflammatory potential of 5H-benzo[h]thiazolo[2,3-b]quinazoline analogues: novel series of anticancer compounds. Int Immunopharmacol. 2024; 137: 112496.

[11] Zhao Z, Qin J, Qian Y, et al. FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion. J Hematol Oncol. 2024; 17(1): 9.

[12] Benedetti F, Silvestri G, Denaro F, et al. Mycoplasma DnaK expression increases cancer development in vivo upon DNA damage. Proc Natl Acad Sci USA. 2024; 121(10): e2320859121.

[13] Fan J, Z G, Lin A, Jia C. BPDE induces apoptosis while melatonin protects in spermatogonial GC-1 cells. J Third Mil Med Univ. 2017; 39(23): 2323-2328.

[14] Liu Y, Ouyang L, Mao C, et al. Inhibition of RNF182 mediated by bap promotes non-small cell lung cancer progression. Front Oncol. 2023; 12: 1009508.

[15] Thongararm P, Fedeles BI, Khumsubdee S, et al. Modulation of N-methyl-N-nitrosourea mutagenesis in mouse embryo fibroblasts derived from the gpt Delta mouse by an inhibitor of the O6-methylguanine methyltransferase, MGMT. Chem Res Toxicol. 2020; 33(2): 625-633.

[16] Westcott PM, Halliwill KD, To, MD, et al. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature. 2015; 517(7535): 489-492.

[17] Hu Y, Yin F, Yu Z, et al. Trans, trans-2,4-decadienal impairs vascular endothelial function by inducing oxidative/nitrative stress and apoptosis. Redox Biol. 2020; 34: 101577.

[18] Liu WB, Ao L, Zhou ZY, et al. CpG Island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Biochem Biophys Res Commun. 2010; 402(3): 507-514.

[19] Liu WB, Cui ZH, Ao L, et al. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a. Toxicol Appl Pharmacol. 2011; 251(1): 70-78.

[20] Liu WB, Liu JY, Ao L, et al. Epigenetic silencing of cell cycle regulatory genes during 3-methylcholanthrene and diethylnitrosamine-induced multistep rat lung cancer. Mol Carcinog. 2010; 49(6): 556-565.

[21] Liu CH, Chen Z, Chen K, et al. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy. Cancer Res. 2021; 81(1): 144-157.

[22] Gao M, Zhang P, Huang L, et al. Is NLRP3 or NLRP6 inflammasome activation associated with inflammation-related lung tumorigenesis induced by benzo(a)pyrene and lipopolysaccharide? Ecotoxicol Environ Saf. 2019; 185: 109687.

[23] Gu Q, Hu C, Chen N, Qu J. A comparison between lung carcinoma and a subcutaneous malignant tumor induced in rats by a 3,4-benzopyrene injection. Int J Clin Exp Pathol. 2018; 11(8): 3934-3942.

[24] Su L, Zhang F, Liu MX, et al. The Tian-men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer. J Ethnopharmacol. 2023; 313: 116491.

[25] Tanaka R, Yoshinouchi S, Karouji K, et al. A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology. FEBS Open Bio. 2023; 13(1): 51-59.

[26] Park SH, Yoon SJ, Choi S, et al. Particulate matter promotes cancer metastasis through increased HBEGF expression in macrophages. Exp Mol Med. 2022; 54(11): 1901-1912.

[27] Mottaghitalab F, Kiani M, Farokhi M, et al. Targeted delivery system based on gemcitabine-loaded silk fibroin nanoparticles for lung cancer therapy. ACS Appl Mater Interfaces. 2017; 9(37): 31600-31611.

[28] Lin G, Lin L, Chen X, et al. PPAR-γ/NF-kB/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6. Cell Death Dis. 2024; 15(7): 532.

[29] Yin Y, Wang Y, Wang C, et al. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis. J Ethnopharmacol. 2024; 326: 117984.

[30] Zhang X, Liu Y, Peng X, et al. Influence of the vaccinating density of A549 cells on tumorigenesis and distant organ metastasis in a lung cancer mice model. Cell Mol Biol (Noisy-le-Grand). 2018; 64(6): 53-57.

[31] Tang S, Yang R, Zhou X, Pan H, Liu J. Expression of GOLPH3 in patients with non-small cell lung cancer and xenografts models. Oncol Lett. 2018; 15(5): 7555-7562.

[32] Russo MV, Faversani A, Gatti S, et al. A new mouse avatar model of non-small cell lung cancer. Front Oncol. 2015; 5: 52.

[33] Shrestha N, Lateef Z, Martey O, et al. Does the mouse tail vein injection method provide a good model of lung cancer? F1000Res. 2019; 8: 190.

[34] Cheng G, Wu J, Ji M, Hu W, Wu C, Jiang J. TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway. BMC Cancer. 2023; 23(1): 825.

[35] Wang Z, Lei Z, Wang Y, et al. Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination. Oncogene. 2024; 43(28): 2215-2227.

[36] Zhang F, Ying L, Jin J, et al. GAP43, a novel metastasis promoter in non-small cell lung cancer. J Transl Med. 2018; 16(1): 310.

[37] Masuda C, Morinaga M, Wakita D, et al. PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion. Clin Exp Metastasis. 2022; 39(2): 335-344.

[38] Lee JE, Park J, Kim EJ, et al. Noggin contributes to brain metastatic colonization of lung cancer cells. Cancer Cell Int. 2023; 23(1): 299.

[39] Lou W, Zhang MD, Chen Q, et al. Molecular mechanism of benzo [a] pyrene regulating lipid metabolism via aryl hydrocarbon receptor. Lipids Health Dis. 2022; 21(1): 13.

[40] Sheinin M, Jeong B, Paidi RK, Pahan K. Regression of lung cancer in mice by intranasal administration of SARS-CoV-2 spike S1. Cancers (Basel). 2022; 14(22): 5648.

[41] Zhou J, Xiong R, Zhou J, et al. Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK. Toxicol Appl Pharmacol. 2022; 436: 115849.

[42] Razani-Boroujerdi S, Sopori ML. Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility. Am J Respir Cell Mol Biol. 2007; 36(1): 13-19.

[43] Narayanapillai SC, Lin SH, Leitzman P, Upadhyaya P, Baglole CJ, Xing C. Dihydromethysticin (DHM) blocks tobacco carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced O6-methylguanine in a manner independent of the aryl hydrocarbon receptor (AhR) pathway in C57BL/6 female mice. Chem Res Toxicol. 2016; 29(11): 1828-1834.

[44] Liu L, Liu X, Ma X, Ning B, Wan X. Analysis of the associations of indoor air pollution and tobacco use with morbidity of lung cancer in Xuanwei, China. Sci Total Environ. 2020; 717: 135232.

[45] Qu Z, Tian J, Sun J, et al. Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer via modulating gut microbiota and the PPARγ/NF-κB pathway. Food Funct. 2024; 15(1): 158-171.

[46] Min HY, Boo HJ, Lee HJ, et al. Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation. Oncotarget. 2016; 7(43): 70936-70947.

[47] Song JM, Upadhyaya P, Kassie F. Nitric oxide-donating aspirin (NO-aspirin) suppresses lung tumorigenesis in vitro and in vivo and these effects are associated with modulation of the EGFR signaling pathway. Carcinogenesis. 2018; 39(7): 911-920.

[48] Ou WT, Wan QX, Wu YB, et al. Long noncoding RNA PSMB8-AS1 mediates the tobacco-carcinogen-induced transformation of a human bronchial epithelial cell line by regulating cell cycle. Chem Res Toxicol. 2024; 37(6): 957-967.

[49] Hudlikar RR, Pai V, Kumar R, et al. Dose-related modulatory effects of polymeric black tea polyphenols (PBPs) on initiation and promotion events in B(a)P and NNK-induced lung carcinogenesis. Nutr Cancer. 2019; 71(3): 508-523.

[50] Tackett AP, Dai HD, Han DH, et al. Appeal of e-cigarette flavors: differences between never and ever use of combustible cigarettes. Drug Alcohol Depend. 2023; 246: 109849.

[51] Duko B, Pereira G, Tait RJ, Nyadanu SD, Betts K, Alati R. Prenatal tobacco exposure and the risk of tobacco smoking and dependence in offspring: a systematic review and meta-analysis. Drug Alcohol Depend. 2021; 227: 108993.

[52] Chen J, Cao S, Jin Y, et al. Construction and validation of a nomogram of risk factors for new-onset atrial fibrillation in advanced lung cancer patients after non-surgical therapy. Front Oncol. 2023; 13: 1125592.

[53] Chen Z, Rao X, Sun L, et al. Yi-Fei-san-Jie Chinese medicine formula reverses immune escape by regulating deoxycholic acid metabolism to inhibit TGR5/STAT3/PD-L1 axis in lung cancer. Phytomedicine. 2024; 135: 156175.

[54] Abdallah FM, Ghoneim AI, Abd-Alhaseeb MM, Abdel-Raheem IT, Helmy MW. Unveiling the antitumor synergy between pazopanib and metformin on lung cancer through suppressing p-Akt/ NF-κB/ STAT3/ PD-L1 signal pathway. Biomed Pharmacother. 2024; 180: 117468.

[55] Satoh H, Arai Y, Furukawa E, et al. Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels. Carcinogenesis. 2022; 43(7): 613-623.

[56] Zhou H, Saliba J, Sandusky GE, Sears CR. XPC protects against smoking- and carcinogen-induced lung adenocarcinoma. Carcinogenesis. 2019; 40(3): 403-411.

[57] Parra ER, Bielecki LC, Ribeiro JM, Andrade Balsalobre F, Teodoro WR, Capelozzi VL. Association between decreases in type V collagen and apoptosis in mouse lung chemical carcinogenesis: a preliminary model to study cancer cell behavior. Clinics (Sao Paulo). 2010; 65(4): 425-432.

[58] Zerbe LK, Dwyer-Nield LD, Fritz JM, et al. Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice. Cancer Chemother Pharmacol. 2008; 62(4): 605-620.

[59] Li S, Counter CM. Non-canonical genomic driver mutations of urethane carcinogenesis. PLoS One. 2022; 17(4): e0267147.

[60] Li S, MacAlpine DM, Counter CM. Capturing the primordial Kras mutation initiating urethane carcinogenesis. Nat Commun. 2020; 11(1): 1800.

[61] Chen X, Zhang T, Su W, et al. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 2022; 13(11): 974.

[62] Simanullang RH, Ilyas S, Hutahaean S, Rosidah . Effect of Andaliman (Zanthoxylum acanthopodium DC.) methanol extract on rat's kidney and liver histology induced by Benzopyrene. Pak J Biol Sci. 2021; 24: 274-281.

[63] Bukowska B, Duchnowicz P. Molecular mechanisms of action of selected substances involved in the reduction of benzo[a]pyrene-induced oxidative stress. Molecules. 2022; 27(4): 1379.

[64] Zhou C, Hu J. Research progress in cancer epigenetics mechanisms of benzo (a) pyrene. Chin J Pharmacol Toxicol. 2017; 31(5): 375-384.

[65] Dang Z, Liu S, Wang X, Ren F, Hussain SA, Jia D. Protective effect of avicularin against lung cancer via inhibiting inflammation, oxidative stress, and induction of apoptosis: an in vitro and in vivo study. In Vitro Cell Dev Biol Anim. 2024; 60(4): 374-381.

[66] Khan A, Alhumaydhi FA, Alwashmi ASS, et al. Diallyl sulfide-mediated modulation of the fatty acid synthase (FASN) leads to cancer cell death in BaP-induced lung carcinogenesis in swiss mice. J Inflamm Res. 2020; 13: 1075-1087.

[67] Qiu L, Chen X, Guo B, et al. Unraveling the protective role of Nrf2 in molluscs: insights into mitochondrial and apoptosis pathways in the defense against bap-induced oxidative stress. Aquat Toxicol. 2023; 264: 106728.

[68] Kohli K, Pillarisetty VG. Dendritic cells in the tumor microenvironment. Adv Exp Med Biol. 2020; 1273: 29-38.

[69] Abd El-Fattah EE, Abdelhamid AM. Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung. Toxicology. 2021; 463: 152994.

[70] Du X, Li D, Wang G, et al. Chemoprotective effect of atorvastatin against benzo(a)pyrene-induced lung cancer via the inhibition of oxidative stress and inflammatory parameters. Ann Transl Med. 2021; 9(4): 355.

[71] Mu W, Gu P, Li H, et al. Exposure of benzo[a]pyrene induces HCC exosome-circular RNA to activate lung fibroblasts and trigger organotropic metastasis. Cancer Commun (Lond). 2024; 44(7): 718-738.

[72] Adachi K, Ishizawa M, Uno S, et al. Oral benzo[a]pyrene administration attenuates dextran sulfate sodium-induced colitis in mice. Chem Biol Interact. 2022; 353: 109802.

[73] Kim NW, Seo SM, Yoo ES, et al. Short-term carcinogenicity study of N-methyl-N-nitrosourea in FVB-Trp53 heterozygous mice. PLoS One. 2023; 18(1): e0280214.

[74] Salehi-Rad R, Li R, Tran LM, et al. Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden. Cancer Immunol Immunother. 2021; 70(8): 2389-2400.

[75] Saggese P, Martinez CA, Tran LM, et al. Genotoxic treatment enhances immune response in a genetic model of lung cancer. Cancers (Basel). 2021; 13(14): 3595.

[76] Lin P, Lee HL, Cheng HI, Chen CY, Tsai MH, Liu HJ. Metabolomic profiling of mice urine and serum associated with trans-trans 2, 4-decadienal induced lung lesions by liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2014; 406(17): 4287-4297.

[77] Hu Y, Zhao G, Qin L, et al. Trans,trans-2,4-decadienal induces endothelial cell injury by impairing mitochondrial function and autophagic flux. Food Funct. 2021; 12(12): 5488-5500.

[78] Wang Y, Dattmore DA, Wang W, et al. Trans, trans-2,4-decadienal, a lipid peroxidation product, induces inflammatory responses via Hsp90- or 14-3-3ζ-dependent mechanisms. J Nutr Biochem. 2020; 76: 108286.

[79] Wang CK, Chang LW, Chang H, et al. Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes. Eur Respir J. 2010; 35(3): 667-675.

[80] Sudakov NP, Klimenkov IV, Bedoshvili YD, et al. Early structural and functional changes in Baikal sculpin gills exposed to suspended soot microparticles in experiment. Chemosphere. 2022; 290: 133241.

[81] Li Y, Dang W, Jiao T, Zhang M, Li W. Silencing PPAP2C inhibits lung adenocarcinoma migration and invasion via the ERK/JNK pathway. Mol Med Rep. 2025; 31(1): 27.

[82] Huang H, Yang Y, Song T, et al. Single-cell RNA sequencing uncovered the involvement of an endothelial subset in neutrophil recruitment in chemically induced rat pulmonary inflammation. Int J Med Sci. 2022; 19(4): 669-680.

[83] Ohnishi T, Fukamachi K, Ohshima Y, et al. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens. Toxicol Pathol. 2007; 35(3): 436-443.

[84] Sotty J, Bablon P, Weiss PH, Soussan P. Diethylnitrosamine induction of hepatocarcinogenesis in mice. Methods Mol Biol. 2024; 2769: 15-25.

[85] Wen LX, Lv JJ, Chen L, Li SB, Mou XJ, Xu Y. A fluorescent probe composed of quantum dot labeled aptamer and graphene oxide for the determination of the lipopolysaccharide endotoxin. Mikrochim Acta. 2019; 186(2): 122.

[86] Melkamu T, Qian X, Upadhyaya P, O'Sullivan MG, Kassie F. Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer. Vet Pathol. 2013; 50(5): 895-902.

[87] Hua Q, Liu Y, Li M, et al. Upregulation of Circ_0035266 contributes to the malignant progression of inflammation-associated malignant transformed cells induced by tobacco-specific carcinogen NNK. Toxicol Sci. 2022; 189(2): 203-215.

[88] Wang S, Li L, Wang W. Knockdown of Slfn5 alleviates lipopolysaccharide-induced pneumonia by regulating Janus kinase/signal transduction and activator of transcription pathway. J Thorac Dis. 2023; 15(12): 6708-6720.

[89] Houel A, Riffard C. Comparative automated quantification of tertiary lymphoid structures in two distinct mouse models of inflammation. Methods Mol Biol. 2025; 2864: 141-157.

[90] Li C, Liu JH, Su J, et al. LncRNA XIST knockdown alleviates LPS-induced acute lung injury by inactivation of XIST/miR-132-3p/MAPK14 pathway: XIST promotes ALI via miR-132-3p/MAPK14 axis. Mol Cell Biochem. 2021; 476(12): 4217-4229.

[91] Wilson AN, Chen B, Liu X, Kurie JM, Kim J. A method for orthotopic transplantation of lung cancer in mice. Methods Mol Biol. 2022; 2374: 231-242.

[92] Gu Q, Hu C, Chen Q, Xia Y, Feng J, Yang H. Development of a rat model by 3,4-benzopyrene intra-pulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl-2 expression in lung carcinoma. Cancer Detect Prev. 2009; 32(5-6): 444-451.

[93] Matsui T, Taniguchi S, Ishii M. Function of alveolar macrophages in lung cancer microenvironment. Inflamm Regen. 2024; 44(1): 23.

[94] Ma Z, Wang H, Shi Z, et al. Inhalable GSH-triggered nanoparticles to treat commensal bacterial infection in in situ lung tumors. ACS Nano. 2023; 17(6): 5740-5756.

[95] Wang Y, Iguchi K, Ito H, et al. Blood flow velocity is reduced in a tumor micro-dissemination in the visceral pleura in anesthetized open-chest rat lung. In Vivo. 2009; 23(2): 291-295.

[96] Sozio F, Schioppa T, Sozzani S, Del Prete A. Urethane-induced lung carcinogenesis. Methods Cell Biol. 2021; 163: 45-57.

[97] Battistoni A, Lantier L, di Tommaso A, et al. Nasal administration of recombinant Neospora caninum secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lung. J Immunother Cancer. 2023; 11(5): e006683.

[98] Li A, Cai X, Li D, et al. Nasal mRNA Nanovaccine with key activators of dendritic and MAIT cells for effective against lung tumor metastasis in mice model. Int J Nanomedicine. 2024; 19: 11479-11497.

[99] Mahiswar AP, Dubey PK, Ranjan A. Comparison between dexmedetomidine and fentanyl bolus in attenuating the stress response to laryngoscopy and tracheal intubation: a randomized double-blind trial. Braz J Anesthesiol. 2022; 72(1): 103-109.

[100] Bai T, Guo J, Deng Y, et al. A systematical strategy for quality markers screening of different methods processing Platycodonis radix based on phytochemical analysis and the impact on chronic obstructive pulmonary disease. J Ethnopharmacol. 2024; 319(Pt 2): 117311.

[101] Yang WK, Kim SW, Youn SH, et al. Respiratory protective effects of Korean red ginseng in a mouse model of particulate matter 4-induced airway inflammation. J Ginseng Res. 2023; 47(1): 81-88.

[102] Jiang W, Wang JM, Luo JH, et al. Airway epithelial integrin β4-deficiency exacerbates lipopolysaccharide-induced acute lung injury. J Cell Physiol. 2021; 236(11): 7711-7724.

[103] Durante M, Sgambellone S, Lanzi C, et al. Effects of PARP-1 deficiency and histamine H4 receptor inhibition in an inflammatory model of lung fibrosis in mice. Front Pharmacol. 2019; 10: 525.

[104] Lin MC, Shen CH, Chang D, Wang M. Inhibition of human lung adenocarcinoma growth and metastasis by JC polyomavirus-like particles packaged with an SP-B promoter-driven CD59-specific shRNA. Clin Sci (Lond). 2019; 133(21): 2159-2169.

[105] Greenwell JC, Torres-Gonzalez E, Ritzenthaler JD, Roman J. Interplay between aging, lung inflammation/remodeling, and fibronectin EDA in lung cancer progression. Cancer Biol Ther. 2020; 21(12): 1109-1118.

[106] Iñañez A, Del Rey-Vergara R, Quimis F, et al. The potential of single-transcription factor gene expression by RT-qPCR for subtyping small cell lung cancer. Int J Mol Sci. 2025; 26(3): 1293.

[107] Choi JG, Kim JM, Kang DW, et al. Inoculation of Lewis lung carcinoma cells enhances formalin-induced pain behavior and spinal Fos expression in mice. J Vet Sci. 2017; 18(3): 267-272.

[108] Hou X, Zhou C, Liang Z, et al. Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway. Phytomedicine. 2023; 121: 155093.

[109] Huang Y, Lu Y, Vadlamudi M, et al. Intrapulmonary inoculation of multicellular spheroids to construct an orthotopic lung cancer xenograft model that mimics four clinical stages of non-small cell lung cancer. J Pharmacol Toxicol Methods. 2020; 104: 106885.

[110] Xu Z, Huang Y, Zhu Y, et al. Construction of an orthotopic xenograft model of non-small cell lung cancer mimicking disease progression and predicting drug activities. J Vis Exp. 2024;(207): e66787.

[111] Haney S, Konen J, Marcus AI, Bazhenov M. The complex ecosystem in non small cell lung cancer invasion. PLoS Comput Biol. 2018; 14(5): e1006131.

[112] Shreberk-Shaked M, Dassa B, Sinha S, et al. A division of labor between YAP and TAZ in non-small cell lung cancer. Cancer Res. 2020; 80(19): 4145-4157.

[113] Miao SN, Chai MQ, Liu XY, et al. Exercise accelerates recruitment of CD8+ T cell to promotes anti-tumor immunity in lung cancer via epinephrine. BMC Cancer. 2024; 24(1): 474.

[114] Guan M, Xu W, Bai H, et al. Potential mechanisms underlying inhibition of xenograft lung cancer models by kaempferol: modulation of gut microbiota in activating immune cell function. J Cancer. 2024; 15(5): 1314-1327.

[115] Mishra DK, Creighton CJ, Zhang Y, Chen F, Thrall MJ, Kim MP. Ex vivo four-dimensional lung cancer model mimics metastasis. Ann Thorac Surg. 2015; 99(4): 1149-1156.

[116] Conway JW, Braden J, Wilmott JS, Scolyer RA, Long GV, da Pires Silva I. The effect of organ-specific tumor microenvironments on response patterns to immunotherapy. Front Immunol. 2022; 13: 1030147.

[117] Masuda H, Maruyama T, Hiratsu E, et al. Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/gamma c(null) immunodeficient mice. Proc Natl Acad Sci USA. 2007; 104(6): 1925-1930.

[118] Sun J, Zhang Z, Xia B, Yao T, Ge F, Yan F. Overexpression of PIK3CG in cancer cells promotes lung cancer cell migration and metastasis through enhanced MMPs expression and neutrophil recruitment and activation. Biochem Genet. 2025; 63(2): 1647-1659.

[119] Richardson F, Young GD, Sennello R, et al. The evaluation of E-cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy. Anticancer Res. 2012; 32(2): 537-552.

[120] de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023; 41(3): 374-403.

[121] Vergara D, Simeone P, Franck J, et al. Translating epithelial mesenchymal transition markers into the clinic: novel insights from proteomics. EuPA Open Proteom. 2016; 10: 31-41.

[122] Wei Z, Z TT, C YZ, et al. Research progress of mechanism of pre-metastatic niches formation. Chin Pharmacol Bull. 2018; 34(10): 1348-1351.

[123] Hamidi H, Ivaska J. Author correction: every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2019; 19(3): 179.

[124] Yayan J, Franke KJ, Berger M, Windisch W, Rasche K. Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review. Mol Biol Rep. 2024; 51(1): 165.

[125] Marcazzan S, Dadbin A, Brachi G, et al. Development of lung metastases in mouse models of tongue squamous cell carcinoma. Oral Dis. 2021; 27(3): 494-505.

[126] Thies KA, Steck S, Knoblaugh SE, Sizemore ST. Pathological analysis of lung metastasis following lateral tail-vein injection of tumor cells. J Vis Exp. 2020;(159): e61270

[127] Xie S, Wu Z, Qi Y, Wu B, Zhu X. The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges. Biomed Pharmacother. 2021; 138: 111450.

[128] Lazebnik T, Bunimovich-Mendrazitsky S. Predicting lung cancer's metastats' locations using bioclinical model. Front Med (Lausanne). 2024; 11: 1388702.

[129] Gao L, Yang T, Zhu J, Xu L, Su L, Wang D. Effect of Qiangxin Huoli decoction on rats with adriamycin-induced chronic heart failure. J Tradit Chin Med. 2019; 39(1): 81-88.

[130] Matsumura Y, Zhu Y, Jiang H, et al. Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction. Biomaterials. 2019; 217: 119289.

[131] Fidler IJ. The role of the organ microenvironment in brain metastasis. Semin Cancer Biol. 2011; 21(2): 107-112.

[132] Wu YJ, Muldoon LL, Dickey DT, Lewin SJ, Varallyay CG, Neuwelt EA. Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models. Neoplasia. 2009; 11(2): 187-195.

[133] Senchukova MA, Kalinin EA, Volchenko NN. Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance. World J Clin Oncol. 2024; 15(5): 614-634.

[134] Wu J, Zhang Q, Yang Z, et al. CD248-expressing cancer-associated fibroblasts induce non-small cell lung cancer metastasis via hippo pathway-mediated extracellular matrix stiffness. J Cell Mol Med. 2024; 28(16): e70025.

[135] Hu F, Fong KO, Cheung MPL, et al. DEPDC1B promotes melanoma angiogenesis and metastasis through sequestration of ubiquitin ligase CDC16 to stabilize secreted SCUBE3. Adv Sci (Weinh). 2022; 9(10): e2105226.

[136] Li A, Qi F, Zeng Y, et al. Cryoshocked adipocytes mediated dual-modal strategy combining photodynamic therapy and triptolide palmitate for pulmonary metastatic melanoma treatment. Adv Sci (Weinh). 2025; 12(9): e2414307.

[137] Alia Moosavian S, Hashemi M, Etemad L, Daneshmand S, Salmasi Z. Melanoma-derived exosomes: versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma. Int Immunopharmacol. 2022; 113(Pt A): 109320.

[138] García-Silva S, Benito-Martín A, Nogués L, et al. Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. Nat Cancer. 2021; 2(12): 1387-1405.

[139] Zheng Y, Wang J, Zhao G, et al. Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma. J Immunother Cancer. 2025; 13(1): e010521.

[140] Brodaczewska K, Majewska A, Filipiak-Duliban A, Kieda C. Pten knockout affects drug resistance differently in melanoma and kidney cancer. Pharmacol Rep. 2023; 75(5): 1187-1199.

[141] Sharma D, Singh A, Wilson C, et al. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor. Pediatr Surg Int. 2024; 40(1): 57.

[142] Zhang Y, Wang X, Gu Y, et al. Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells. Proc Natl Acad Sci USA. 2025; 122(4): e2420005122.

[143] Huang Q, Sun Y, Ma X, et al. Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma. Nat Commun. 2017; 8(1): 918.

[144] Jiang B, Zhao X, Chen W, et al. Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation. Nat Commun. 2022; 13(1): 4141.

[145] Tang T, Yang T, Xue H, et al. Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis. Oncogene. 2025; 44(9): 601-617.

[146] Mu Z, Klinowska T, Dong X, et al. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models. J Exp Clin Cancer Res. 2014; 33(1): 47.

[147] Shi K, Fu W, Farhadi Sabet Z, et al. Hydrogel-mediated jamming of exosome communications that Counter tumor adaption in the tumor immune microenvironment. ACS Nano. 2024; 18(48): 33042-33057.

[148] Zhang L, Pan J, Wang M, et al. Chronic stress-induced and tumor derived SP1+ exosomes polarizing IL-1β+ neutrophils to increase lung metastasis of breast cancer. Adv Sci (Weinh). 2025; 12(4): e2310266.

[149] Jiang X, Wang J, Lin L, et al. Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity. Signal Transduct Target Ther. 2024; 9(1): 352.

[150] Ding X, Shi J, Lei Z, et al. FOXM1 promotes malignant biological behavior and metabolic reprogramming by targeting SPINK1 in hepatocellular carcinoma and affecting the p53 pathway. Biochim Biophys Acta Mol basis Dis. 2025; 1871(3): 167673.

[151] Wang P, Qiu J, Fang Y, et al. SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy. Cell Death Differ. 2025.

[152] Haiying Z, Lin W, Huimei Y, Jinghua L, Chao D, Shuang L. Establishment of lung metastasis model of liver cancer in mice. J Med Pest Control. 2023; 39(6): 591-593.

[153] Zhao Y, Yu H, Li J, et al. A glucose-enriched lung pre-metastatic niche triggered by matrix stiffness-tuned exosomal miRNAs in hepatocellular carcinoma. Nat Commun. 2025; 16(1): 1736.

[154] Yu X, Qian J, Ding L, et al. Galectin-1-induced tumor associated macrophages repress antitumor immunity in hepatocellular carcinoma through recruitment of tregs. Adv Sci. 2025; 12(11): e2408788.

[155] Xun L, Jiao Y, Shunli C, Huajian C. HMMR promotes invasion and metastasis of hepatocellular carcinoma via activating MEK/ERK signaling pathway. J Army Med Univ. 2022; 44(17): 1720-1727.

[156] Su T, Huang S, Zhang Y, et al. miR-7/TGF-β2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis. Acta Pharm Sin B. 2022; 12(2): 821-837.

[157] Nicholas Z, Sughrue M, Battiste J, Algan O. When evaluating a new thyroid mass and a ring-enhancing brain lesion (when two presentations collide). Cureus. 2016; 8(5): e600.

[158] Richardo T, Prattapong P, Ngernsombat C, et al. Epstein-Barr virus mediated signaling in nasopharyngeal carcinoma carcinogenesis. Cancers (Basel). 2020; 12(9): 2441.

[159] Miyamoto S, Tanaka T, Hirosuna K, et al. Validation of a patient-derived xenograft model for cervical cancer based on genomic and phenotypic characterization. Cancers (Basel). 2022; 14(12): 2969.

[160] Woo XY, Srivastava A, Mack PC, et al. A Genomically and clinically annotated patient-derived xenograft resource for preclinical research in non-small cell lung cancer. Cancer Res. 2022; 82(22): 4126-4138.

[161] Fang T, Huang H, Li X, et al. Effects of siRNA silencing of TUG1 and LCAL6 Long non-coding RNAs on patient-derived xenograft of non-small cell lung cancer. Anticancer Res. 2018; 38(1): 179-186.

[162] He P, Li H, Yang Z, et al. Discovery and preclinical evaluations of drug candidate DA-0157 capable of overcoming EGFR drug-resistant mutation C797S and EGFR/ALK co-mutations. Eur J Med Chem. 2025; 287: 117323.

[163] Chen Y, Zhang R, Wang L, et al. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer. 2019; 125(21): 3738-3748.

[164] Chen X, Shen C, Wei Z, et al. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity. Cancer Biol Med. 2021; 18(1): 184-198.

[165] Zhuo J, Lu D, Wang J, et al. Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts. Chin J Cancer Res. 2021; 33(4): 470-479.

[166] Hynds RE, Huebner A, Pearce DR, et al. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. Nat Commun. 2024; 15(1): 4653.

[167] Sugimoto T, Takiguchi Y, Kurosu K, et al. Growth factor-mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small-cell lung cancer. Oncol Rep. 2005; 14(4): 823-830.

[168] Liu X, Lu Y, Huang J, et al. CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition. Cancer Cell. 2022; 40(11): 1341-1357.e13.

[169] Xu L, Xu F, Kong Q, et al. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression. Mol Carcinog. 2020; 59(8): 967-979.

[170] Li D, Zhang Y, Xie Y, Xiang J, Zhu Y, Yang J. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer. Cancer Gene Ther. 2013; 20(4): 251-259.

[171] Hokari S, Tamura Y, Kaneda A, et al. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer. Mol Oncol. 2020; 14(2): 277-293.

[172] Zinn RL, Gardner EE, Dobromilskaya I, et al. Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol Cancer. 2013; 12: 16.

[173] Pifano M, Garona J, Capobianco CS, Gonzalez N, Alonso DF, Ripoll GV. Peptide agonists of vasopressin V2 receptor reduce expression of neuroendocrine markers and tumor growth in human lung and prostate tumor cells. Front Oncol. 2017; 7: 11.

[174] Deniz C, Gedik T, Yüksel B, Cebeci E, Şahin F. Anti-cancer effect of sodium pentaborate in combination with cisplatin on lung cancer cell lines. Mol Biol Rep. 2024; 52(1): 28.

[175] Cao S, Wang Y, Zhou Y, et al. A novel therapeutic target for small-cell lung cancer: tumor-associated repair-like Schwann cells. Cancers (Basel). 2022; 14(24): 6132.

[176] Liang SK, Hsu CC, Song HL, et al. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis. Oncogene. 2021; 40(30): 4847-4858. Erratum in: Oncogene. 2021;40(49):6705.

[177] Ferguson MW, Gerak CAN, Chow CCT, et al. The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418. PLoS One. 2019; 14(5): e0216423.

[178] Mukherjee S, Suresh D, Zambre A, et al. Synergistic inhibition of drug resistant KRAS mutant non-small cell lung cancer by Co-targeting AXL and SRC. Cancers (Basel). 2025; 17(3): 490.

[179] Meraz IM, Majidi M, Song R, et al. NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model. elife. 2025; 13: RP98258.

[180] Li S, Wang K, Zhu X, et al. The diagnostic value of 68Ga-NOTA-MAL-Cys-MZHER2:342 PET/CT imaging for HER2-positive lung adenocarcinoma. Front Med. 2024; 11: 1447500.

[181] Singh SS, Mattheolabakis G, Gu X, Withers S, Dahal A, Jois S. A grafted peptidomimetic for EGFR heterodimerization inhibition: implications in NSCLC models. Eur J Med Chem. 2021; 216: 113312.

[182] Fang L, Zhu R, Li M, et al. Silica-based EGFR-degrading nano-PROTACs for efficient therapy of non-small cell lung cancer. Eur J Pharm Biopharm. 2025; 210: 114699.

[183] Cho JH, You YM, Koo H, Lee DC, Yeom YI, Park KC. LPIN1 induces gefitinib resistance in EGFR inhibitor-resistant non-small cell lung cancer cells. Cancers (Basel). 2022; 14(9): 2222.

[184] Li L, Zhao H, Peng X, et al. Discovery of novel quinazoline-based KRAS G12C inhibitors as potential anticancer agents. Bioorg Med Chem. 2022; 71: 116962.

[185] Han SY, Zhao W, Sun H, et al. Marsdenia tenacissima extract enhances gefitinib efficacy in non-small cell lung cancer xenografts. Phytomedicine. 2015; 22(5): 560-567.

[186] Ma J, Liu J, Lu C, Cai D. Pachymic acid induces apoptosis via activating ROS-dependent JNK and ER stress pathways in lung cancer cells. Cancer Cell Int. 2015; 15: 78.

[187] Wu J, Xie K, Zhang Y, et al. RASON promotes KRASG12C-driven tumor progression and immune evasion in non-small cell lung cancer. J Exp Clin Cancer Res. 2025; 44(1): 106.

[188] Du F, Zhang A, Qi X, Yin R, Jiang T, Li J. Novel Camptothecin derivative 9c with enhanced antitumor activity via NSA2-EGFR-P53 signaling pathway. Int J Mol Sci. 2025; 26(5): 1987.

[189] Yan L, Liu Y, Huang Y, et al. Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism. Cancer Biol Med. 2025; 22(2): 144-165.

[190] Ding J, Jia W, Cui Y, et al. Anti-angiogenic effect of a chemically sulfated polysaccharide from Phellinus ribis by inhibiting VEGF/VEGFR pathway. Int J Biol Macromol. 2020; 154(1): 72-81.

[191] Li H, Yang F, Zhang L, Zhao R, Li X, Li H. Xiaoliu Pingyi Pecipe inhibits lung pre-metastatic niche formation and prevents myeloid-derived suppressor cells recruitment. Integr Cancer Ther. 2023; 22: 15347354231187000.

[192] Jiang Y, Liang Y, Li L, et al. Targeting neddylation inhibits intravascular survival and extravasation of cancer cells to prevent lung-cancer metastasis. Cell Biol Toxicol. 2019; 35(3): 233-245.

[193] Mukherjee S, Debata PR, Hussaini R, et al. Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression. Oncotarget. 2017; 8(37): 60904-60916.

[194] Yu J, Peng W, Xue Y, Li Y, Yang L, Geng Y. FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1. Allergol Immunopathol (Madr). 2022; 50(5): 68-74.

[195] Kim MJ, Kim K, Park HJ, et al. Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells. Nat Immunol. 2023; 24(1): 148-161.

[196] Wakefield L, Agarwal S, Tanner K. Preclinical models for drug discovery for metastatic disease. Cell. 2023; 186(8): 1792-1813.

[197] Yang C, Wang X, To, KKW, et al. Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis. Signal Transduct Target Ther. 2024; 9(1): 84.

[198] Dai Z, Gu XY, Xiang SY, Gong DD, Man CF, Fan Y. Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells. Biomark Res. 2020; 8(1): 60.

[199] Würth R, Donato E, Michel LL, et al. Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signaling. Nat Cancer. 2025; 6(1): 67-85.

[200] Deng H, Ge H, Dubey C, et al. An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1. Cancer Immunol Immunother. 2023; 72(12): 4457-4470.

[201] Yamakado T, Sato-Yazawa H, Ishii J, et al. Spontaneous transformation from lung adenocarcinoma to MYC-amplified large cell neuroendocrine carcinoma. Pathol Int. 2025; 75(2): 105-113.

[202] Ciampricotti M, Karakousi T, Richards AL, et al. Rlf-Mycl gene fusion drives tumorigenesis and metastasis in a mouse model of small cell lung cancer. Cancer Discov. 2021; 11(12): 3214-3229.

[203] Martinez-Usatorre A, Kadioglu E, Boivin G, et al. Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models. Sci Transl Med. 2021; 13(606): eabd1616.

[204] Oser MG, MacPherson D, Oliver TG, Sage J, Park KS. Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene. 2024; 43(7): 457-469.

[205] Leibowitz ML, Papathanasiou S, Doerfler PA, et al. Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing. Nat Genet. 2021; 53(6): 895-905.

[206] Lan T, He S, Luo X, et al. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. Ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells. J Ethnopharmacol. 2024; 332: 118340.

[207] Song X, Wang H, Gao Y, Zhang W, Lei X. Synthesis and biological evaluation of the Fluoro analog of Romidepsin with improved selectivity for class I histone deacetylases (HDACs). Bioorg Chem. 2025; 159: 108348.

[208] Wu S, Zhu L, Tu L, et al. AZD9291 increases sensitivity to radiation in PC-9-IR cells by delaying DNA damage repair after irradiation and inducing apoptosis. Radiat Res. 2018; 189(3): 283-291.

[209] Kotani H, Oshima H, Boucher JC, et al. Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage. J Biomed Sci. 2024; 31(1): 68.

[210] McGinnis CS, Miao Z, Superville D, et al. The temporal progression of lung immune remodeling during breast cancer metastasis. Cancer Cell. 2024; 42(6): 1018-1031.e6.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.